Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Aeon Biopharma, Inc.

NYSE: AEON · Life Sciences · 5 alerts · CIK 1837607

Share price
$0.1407Close, Nov 16
Market cap
$11.8M
Shares outstanding
84.12MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Aeon Biopharma, Inc. filings on SEC EDGAR ↗

4:30 PM ET 10-Q
Financial Results

Aeon Biopharma Q3 2026 Results: Turns Profitable, Net Income $2.46M

AEON Biopharma reported a net loss of $10.5 million for the nine months ended September 30, 2026, compared to a $2.1 million loss in the prior year period. The company significantly strengthened its balance sheet through public offerings and PIPE financing, increasing cash and cash equivalents to $11.4 million and reducing total liabilities from $60.6 million to $11.7 million.

Key figure
Net income $2.46M
4:28 PM ET 8-K
Financial Results

Aeon Biopharma Financial Results

AEON Biopharma reported Q3 2026 financial results and provided a regulatory update on its ABP-450 biosimilar program. The company received FDA Type 2b feedback clarifying its development strategy and submitted an IND for a comparative pharmacodynamic study planned for Q1 2027.

Term
Q3 2026

“Over the past several months, we have made important progress in advancing the scientific and regulatory foundation for ABP-450’s development as a biosimilar to BOTOX®.”

Rob Bancroft, President and Chief Executive Officer

“With our CMAP IND submitted and additional capital secured through the recent milestone warrant exercises, we are positioned to advance the next phase of development, including the planned initiation of our comparative pharmacodynamic study in the first quarter of 2027.”

Rob Bancroft, President and Chief Executive Officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.